ACRV
Acrivon Therapeutics, Inc.Company with tickers: ACRV
CIK
1781174
CUSIP
004890109
Shares Outstanding
42,801,729
Website
https://acrivon.com/
13F Activity (30d)
2 filings
1 filers
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-26 | TD Cowen 7th Annual Oncology Innovation Summit | Event |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-27 | Endometrial Cancer KOL Panel Discussing Acrivon’s Phase 2b ACR-368 Study | Event |
| 2025-03-25 | Virtual Corporate R&D Event | Event |
| 2024-09-14 | Corporate R&D Event | Event |
| 2024-04-24 | Virtual Corporate R&D Event | Event |